Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma (Q44968916)

7 December 2017

Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma (English)

1 reference

7 December 2017

Arisa Kumagai

1

1 reference

7 December 2017

Junichi Fukushima

2

1 reference

7 December 2017

Hajime Takikawa

3

1 reference

7 December 2017

Toshio Fukuda

4

1 reference

7 December 2017

Toshio Fukusato

5

1 reference

7 December 2017

1 February 2013

1 reference

7 December 2017

1 reference

7 December 2017

43

1 reference

7 December 2017

9

1 reference

7 December 2017

959-969

1 reference

Hepatocellular carcinoma pathogenesis: from genes to environment

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Identification of a nuclear receptor that is activated by farnesol metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Nuclear receptors as new perspective for the management of liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Nuclear bile acid receptor FXR in the hepatic regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

Effect of preoperative transcatheter arterial chemoembolization on proliferation of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12047

21 January 2018

Identifiers

DOI

10.1111/HEPR.12047

1 reference

release_gkucah34pfdlxol32ikrhkdn4a

7 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gkucah34pfdlxol32ikrhkdn4a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference